Radiotherapy has a role in treating patients with Hodgkin's lymphoma in partial remission
This article has no abstract so we have provided the first paragraph of the full text.
The use of radiotherapy after chemotherapy in patients with Hodgkin's lymphoma is a matter of some debate, but there is evidence to indicate that radiotherapy might improve the outcomes of patients in partial remission (PR) following chemotherapy. To examine the role of radiotherapy in this cohort of patients, Aleman et al. carried out a prospective, randomized trial, enrolling patients with previously untreated stage III–IV Hodgkin's lymphoma.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.